What question did this study set out to answer?

The study aims to analyze ophthalmic medicines registered in Uzbekistan to identify trends in drug registration and composition.

Assortment analysis of ophthalmic medicines in the Republic of Uzbekistan

View Full Paper

Ask AI

Bookmark

The study aims to analyze ophthalmic medicines registered in Uzbekistan to identify trends in drug registration and composition.
Analyzed data from the State Register for medicines classified under Anatomical Therapeutic Chemical S01 (2010–2024).
Utilized marketing and qualimetric methods to assess International Nonproprietary Names, dosage forms, and manufacturers.
Focused on trends in registered items and their sources.
Registered ophthalmic medicines peaked at 352 in 2022, declining to 279 in 2024.
Eye drops accounted for 65% of registered items, totaling 182 items.
Domestic product share increased to 22%, and combined therapies constituted 32% of the offerings.

No takes yet. Share an insight, caveat, or question.

Assortment analysis reveals trends in ophthalmic medicine registration in Uzbekistan, indicating market growth and changes in composition.

Usmonova et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Assortment analysis reveals trends in ophthalmic medicine registration in Uzbekistan, indicating market growth and changes in composition.